The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cachexia Treatment Market Research Report 2025
Synopsis
Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in the late stages of severe diseases like cancer, HIV or AIDS, kidney disease, COPD and congestive heart failure (CHF). Appetite stimulants, anti-inflammatory drugs, Corticosteroids, Enobosarm and Other Anabolics are most commonly used for cachexia treatment.
The global Cachexia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cachexia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cachexia Treatment.
Report Scope
The Cachexia Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cachexia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cachexia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alder Biopharmaceuticals Inc.
GTx Inc.
Helsinn Group
Merck & Co. Inc.
Bristol-Myers Squibb Company
Helsinn Healthcare S.A.
PsiOxus
Purdue Pharma L.P.
Eterna Zentaris Inc.
Aphios Corporation
Neurim
Novartis AG
SkyePharma
Segment by Type
Weight Loss Stabilizers
Appetite Stimulants
Progestogens
Corticosteroids
Combination therapies
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cachexia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in the late stages of severe diseases like cancer, HIV or AIDS, kidney disease, COPD and congestive heart failure (CHF). Appetite stimulants, anti-inflammatory drugs, Corticosteroids, Enobosarm and Other Anabolics are most commonly used for cachexia treatment.
The global Cachexia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cachexia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cachexia Treatment.
Report Scope
The Cachexia Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cachexia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cachexia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alder Biopharmaceuticals Inc.
GTx Inc.
Helsinn Group
Merck & Co. Inc.
Bristol-Myers Squibb Company
Helsinn Healthcare S.A.
PsiOxus
Purdue Pharma L.P.
Eterna Zentaris Inc.
Aphios Corporation
Neurim
Novartis AG
SkyePharma
Segment by Type
Weight Loss Stabilizers
Appetite Stimulants
Progestogens
Corticosteroids
Combination therapies
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cachexia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cachexia Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Weight Loss Stabilizers
1.2.3 Appetite Stimulants
1.2.4 Progestogens
1.2.5 Corticosteroids
1.2.6 Combination therapies
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cachexia Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cachexia Treatment Market Perspective (2019-2030)
2.2 Cachexia Treatment Growth Trends by Region
2.2.1 Global Cachexia Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cachexia Treatment Historic Market Size by Region (2019-2024)
2.2.3 Cachexia Treatment Forecasted Market Size by Region (2025-2030)
2.3 Cachexia Treatment Market Dynamics
2.3.1 Cachexia Treatment Industry Trends
2.3.2 Cachexia Treatment Market Drivers
2.3.3 Cachexia Treatment Market Challenges
2.3.4 Cachexia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cachexia Treatment Players by Revenue
3.1.1 Global Top Cachexia Treatment Players by Revenue (2019-2024)
3.1.2 Global Cachexia Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Cachexia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cachexia Treatment Revenue
3.4 Global Cachexia Treatment Market Concentration Ratio
3.4.1 Global Cachexia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cachexia Treatment Revenue in 2023
3.5 Cachexia Treatment Key Players Head office and Area Served
3.6 Key Players Cachexia Treatment Product Solution and Service
3.7 Date of Enter into Cachexia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cachexia Treatment Breakdown Data by Type
4.1 Global Cachexia Treatment Historic Market Size by Type (2019-2024)
4.2 Global Cachexia Treatment Forecasted Market Size by Type (2025-2030)
5 Cachexia Treatment Breakdown Data by Application
5.1 Global Cachexia Treatment Historic Market Size by Application (2019-2024)
5.2 Global Cachexia Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cachexia Treatment Market Size (2019-2030)
6.2 North America Cachexia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cachexia Treatment Market Size by Country (2019-2024)
6.4 North America Cachexia Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cachexia Treatment Market Size (2019-2030)
7.2 Europe Cachexia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cachexia Treatment Market Size by Country (2019-2024)
7.4 Europe Cachexia Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cachexia Treatment Market Size (2019-2030)
8.2 Asia-Pacific Cachexia Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cachexia Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Cachexia Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cachexia Treatment Market Size (2019-2030)
9.2 Latin America Cachexia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cachexia Treatment Market Size by Country (2019-2024)
9.4 Latin America Cachexia Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cachexia Treatment Market Size (2019-2030)
10.2 Middle East & Africa Cachexia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cachexia Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Cachexia Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alder Biopharmaceuticals Inc.
11.1.1 Alder Biopharmaceuticals Inc. Company Detail
11.1.2 Alder Biopharmaceuticals Inc. Business Overview
11.1.3 Alder Biopharmaceuticals Inc. Cachexia Treatment Introduction
11.1.4 Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2019-2024)
11.1.5 Alder Biopharmaceuticals Inc. Recent Development
11.2 GTx Inc.
11.2.1 GTx Inc. Company Detail
11.2.2 GTx Inc. Business Overview
11.2.3 GTx Inc. Cachexia Treatment Introduction
11.2.4 GTx Inc. Revenue in Cachexia Treatment Business (2019-2024)
11.2.5 GTx Inc. Recent Development
11.3 Helsinn Group
11.3.1 Helsinn Group Company Detail
11.3.2 Helsinn Group Business Overview
11.3.3 Helsinn Group Cachexia Treatment Introduction
11.3.4 Helsinn Group Revenue in Cachexia Treatment Business (2019-2024)
11.3.5 Helsinn Group Recent Development
11.4 Merck & Co. Inc.
11.4.1 Merck & Co. Inc. Company Detail
11.4.2 Merck & Co. Inc. Business Overview
11.4.3 Merck & Co. Inc. Cachexia Treatment Introduction
11.4.4 Merck & Co. Inc. Revenue in Cachexia Treatment Business (2019-2024)
11.4.5 Merck & Co. Inc. Recent Development
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Detail
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Cachexia Treatment Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2019-2024)
11.5.5 Bristol-Myers Squibb Company Recent Development
11.6 Helsinn Healthcare S.A.
11.6.1 Helsinn Healthcare S.A. Company Detail
11.6.2 Helsinn Healthcare S.A. Business Overview
11.6.3 Helsinn Healthcare S.A. Cachexia Treatment Introduction
11.6.4 Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2019-2024)
11.6.5 Helsinn Healthcare S.A. Recent Development
11.7 PsiOxus
11.7.1 PsiOxus Company Detail
11.7.2 PsiOxus Business Overview
11.7.3 PsiOxus Cachexia Treatment Introduction
11.7.4 PsiOxus Revenue in Cachexia Treatment Business (2019-2024)
11.7.5 PsiOxus Recent Development
11.8 Purdue Pharma L.P.
11.8.1 Purdue Pharma L.P. Company Detail
11.8.2 Purdue Pharma L.P. Business Overview
11.8.3 Purdue Pharma L.P. Cachexia Treatment Introduction
11.8.4 Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2019-2024)
11.8.5 Purdue Pharma L.P. Recent Development
11.9 Eterna Zentaris Inc.
11.9.1 Eterna Zentaris Inc. Company Detail
11.9.2 Eterna Zentaris Inc. Business Overview
11.9.3 Eterna Zentaris Inc. Cachexia Treatment Introduction
11.9.4 Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2019-2024)
11.9.5 Eterna Zentaris Inc. Recent Development
11.10 Aphios Corporation
11.10.1 Aphios Corporation Company Detail
11.10.2 Aphios Corporation Business Overview
11.10.3 Aphios Corporation Cachexia Treatment Introduction
11.10.4 Aphios Corporation Revenue in Cachexia Treatment Business (2019-2024)
11.10.5 Aphios Corporation Recent Development
11.11 Neurim
11.11.1 Neurim Company Detail
11.11.2 Neurim Business Overview
11.11.3 Neurim Cachexia Treatment Introduction
11.11.4 Neurim Revenue in Cachexia Treatment Business (2019-2024)
11.11.5 Neurim Recent Development
11.12 Novartis AG
11.12.1 Novartis AG Company Detail
11.12.2 Novartis AG Business Overview
11.12.3 Novartis AG Cachexia Treatment Introduction
11.12.4 Novartis AG Revenue in Cachexia Treatment Business (2019-2024)
11.12.5 Novartis AG Recent Development
11.13 SkyePharma
11.13.1 SkyePharma Company Detail
11.13.2 SkyePharma Business Overview
11.13.3 SkyePharma Cachexia Treatment Introduction
11.13.4 SkyePharma Revenue in Cachexia Treatment Business (2019-2024)
11.13.5 SkyePharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cachexia Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Weight Loss Stabilizers
Table 3. Key Players of Appetite Stimulants
Table 4. Key Players of Progestogens
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Combination therapies
Table 7. Key Players of Others
Table 8. Global Cachexia Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Cachexia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Cachexia Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Cachexia Treatment Market Share by Region (2019-2024)
Table 12. Global Cachexia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Cachexia Treatment Market Share by Region (2025-2030)
Table 14. Cachexia Treatment Market Trends
Table 15. Cachexia Treatment Market Drivers
Table 16. Cachexia Treatment Market Challenges
Table 17. Cachexia Treatment Market Restraints
Table 18. Global Cachexia Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Cachexia Treatment Market Share by Players (2019-2024)
Table 20. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cachexia Treatment as of 2023)
Table 21. Ranking of Global Top Cachexia Treatment Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Cachexia Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cachexia Treatment Product Solution and Service
Table 25. Date of Enter into Cachexia Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cachexia Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Cachexia Treatment Revenue Market Share by Type (2019-2024)
Table 29. Global Cachexia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Cachexia Treatment Revenue Market Share by Type (2025-2030)
Table 31. Global Cachexia Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Cachexia Treatment Revenue Market Share by Application (2019-2024)
Table 33. Global Cachexia Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Cachexia Treatment Revenue Market Share by Application (2025-2030)
Table 35. North America Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Cachexia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Cachexia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Cachexia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Cachexia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Cachexia Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Cachexia Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Cachexia Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Cachexia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Cachexia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Cachexia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Cachexia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cachexia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 50. Alder Biopharmaceuticals Inc. Company Detail
Table 51. Alder Biopharmaceuticals Inc. Business Overview
Table 52. Alder Biopharmaceuticals Inc. Cachexia Treatment Product
Table 53. Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 54. Alder Biopharmaceuticals Inc. Recent Development
Table 55. GTx Inc. Company Detail
Table 56. GTx Inc. Business Overview
Table 57. GTx Inc. Cachexia Treatment Product
Table 58. GTx Inc. Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 59. GTx Inc. Recent Development
Table 60. Helsinn Group Company Detail
Table 61. Helsinn Group Business Overview
Table 62. Helsinn Group Cachexia Treatment Product
Table 63. Helsinn Group Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 64. Helsinn Group Recent Development
Table 65. Merck & Co. Inc. Company Detail
Table 66. Merck & Co. Inc. Business Overview
Table 67. Merck & Co. Inc. Cachexia Treatment Product
Table 68. Merck & Co. Inc. Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 69. Merck & Co. Inc. Recent Development
Table 70. Bristol-Myers Squibb Company Company Detail
Table 71. Bristol-Myers Squibb Company Business Overview
Table 72. Bristol-Myers Squibb Company Cachexia Treatment Product
Table 73. Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 74. Bristol-Myers Squibb Company Recent Development
Table 75. Helsinn Healthcare S.A. Company Detail
Table 76. Helsinn Healthcare S.A. Business Overview
Table 77. Helsinn Healthcare S.A. Cachexia Treatment Product
Table 78. Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 79. Helsinn Healthcare S.A. Recent Development
Table 80. PsiOxus Company Detail
Table 81. PsiOxus Business Overview
Table 82. PsiOxus Cachexia Treatment Product
Table 83. PsiOxus Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 84. PsiOxus Recent Development
Table 85. Purdue Pharma L.P. Company Detail
Table 86. Purdue Pharma L.P. Business Overview
Table 87. Purdue Pharma L.P. Cachexia Treatment Product
Table 88. Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 89. Purdue Pharma L.P. Recent Development
Table 90. Eterna Zentaris Inc. Company Detail
Table 91. Eterna Zentaris Inc. Business Overview
Table 92. Eterna Zentaris Inc. Cachexia Treatment Product
Table 93. Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 94. Eterna Zentaris Inc. Recent Development
Table 95. Aphios Corporation Company Detail
Table 96. Aphios Corporation Business Overview
Table 97. Aphios Corporation Cachexia Treatment Product
Table 98. Aphios Corporation Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 99. Aphios Corporation Recent Development
Table 100. Neurim Company Detail
Table 101. Neurim Business Overview
Table 102. Neurim Cachexia Treatment Product
Table 103. Neurim Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 104. Neurim Recent Development
Table 105. Novartis AG Company Detail
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Cachexia Treatment Product
Table 108. Novartis AG Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 109. Novartis AG Recent Development
Table 110. SkyePharma Company Detail
Table 111. SkyePharma Business Overview
Table 112. SkyePharma Cachexia Treatment Product
Table 113. SkyePharma Revenue in Cachexia Treatment Business (2019-2024) & (US$ Million)
Table 114. SkyePharma Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cachexia Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cachexia Treatment Market Share by Type: 2023 VS 2030
Figure 3. Weight Loss Stabilizers Features
Figure 4. Appetite Stimulants Features
Figure 5. Progestogens Features
Figure 6. Corticosteroids Features
Figure 7. Combination therapies Features
Figure 8. Others Features
Figure 9. Global Cachexia Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Cachexia Treatment Market Share by Application: 2023 VS 2030
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Drug Stores Case Studies
Figure 14. Online Case Studies
Figure 15. Cachexia Treatment Report Years Considered
Figure 16. Global Cachexia Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Cachexia Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Cachexia Treatment Market Share by Region: 2023 VS 2030
Figure 19. Global Cachexia Treatment Market Share by Players in 2023
Figure 20. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cachexia Treatment as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Cachexia Treatment Revenue in 2023
Figure 22. North America Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Cachexia Treatment Market Share by Country (2019-2030)
Figure 24. United States Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Cachexia Treatment Market Share by Country (2019-2030)
Figure 28. Germany Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Cachexia Treatment Market Share by Region (2019-2030)
Figure 36. China Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Cachexia Treatment Market Share by Country (2019-2030)
Figure 44. Mexico Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Cachexia Treatment Market Share by Country (2019-2030)
Figure 48. Turkey Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Cachexia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Alder Biopharmaceuticals Inc. Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 51. GTx Inc. Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 52. Helsinn Group Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 53. Merck & Co. Inc. Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 54. Bristol-Myers Squibb Company Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 55. Helsinn Healthcare S.A. Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 56. PsiOxus Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 57. Purdue Pharma L.P. Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 58. Eterna Zentaris Inc. Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 59. Aphios Corporation Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 60. Neurim Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 61. Novartis AG Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 62. SkyePharma Revenue Growth Rate in Cachexia Treatment Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
